Outcome of patients with extramedullary plasmacytomas (EMPs) included in a phase III pethema/gem study of induction therapy prior autologous stem cell transplantation (ASCT) in multiple myeloma (MM)

Category Primary study
JournalClinical Lymphoma, Myeloma and Leukemia
Year 2015
This article has no abstract
Epistemonikos ID: d4d377026ebf112ea719016093e809c6fb6bfd56
First added on: Feb 07, 2025